There's a big market for new treatments for TB, malaria and other ailments. But most of these diseases afflict low-income people unable to pay for medicine.
Academic rigor, journalistic flair
Articles on Leishmaniasis
Displaying all articles
Each year 50 000 people from 89 countries, in every continent except Antarctica, die from leishmaniasis, an ancient neglected disease.
A team of medievalists and scientists look back to history – including a 1,000-year-old eyesalve recipe – for clues to new antibiotics.
Emerging diseases on which the experts are keeping a close eye.
Top contributors
-
Lecturer, Lancaster University
-
CLIR Postdoctoral Fellow for Data Curation in Medieval Studies, University of Pennsylvania
-
Lecturer and Team Leader: Leishmaniasis Research Group, University of Cape Town
-
PhD Candidate, University of Cape Town
-
Professor of Chemistry; Interim Chair of the Chemistry Department, University of South Florida
